These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11120943)

  • 1. Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii.
    Khan AA; Slifer TR; Araujo FG; Remington JS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):48-51. PubMed ID: 11120943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Nigella sativa oil on experimental toxoplasmosis.
    Mady RF; El-Hadidy W; Elachy S
    Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
    Abugri DA; Witola WH; Russell AE; Troy RM
    Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency.
    Majeed QAH; Alnomasy SF; Shater AF; Alanazi AD
    Acta Parasitol; 2024 Jun; 69(2):1201-1211. PubMed ID: 38634986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effects of doxycycline on Toxoplasma gondii.
    Chang HR; Comte R; Pechère JC
    Antimicrob Agents Chemother; 1990 May; 34(5):775-80. PubMed ID: 2360817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.
    Derouin F; Piketty C; Chastang C; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):252-5. PubMed ID: 2024957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro.
    Galván-Ramírez Mde L; Dueñas Jiménez JM; Rocío Rodríguez Pérez L; Troyo-Sanroman R; Ramírez-Herrera M; García-Iglesias T
    Arch Med Res; 2013 Aug; 44(6):415-21. PubMed ID: 23973195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice.
    Piketty C; Derouin F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1467-72. PubMed ID: 2221854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
    Araujo FG; Huskinson J; Remington JS
    Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trovafloxacin is active against Toxoplasma gondii.
    Khan AA; Slifer T; Araujo FG; Remington JS
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1855-9. PubMed ID: 8843293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA; Lambert LH; Remington JS; Araujo FG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Efficacy of Drugs against Toxoplasma gondii Combined with Immunomodulators.
    Köksal ZŞ; Yanik K; Bilgin K; Yılmaz EM; Hokelek M
    Jpn J Infect Dis; 2016; 69(2):113-7. PubMed ID: 26166498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.